GANDOGLIA, ILARIA
 Distribuzione geografica
Continente #
EU - Europa 1.905
AS - Asia 14
SA - Sud America 3
Totale 1.922
Nazione #
IT - Italia 1.905
CN - Cina 8
SG - Singapore 3
VN - Vietnam 3
AR - Argentina 1
BR - Brasile 1
PE - Perù 1
Totale 1.922
Città #
Genova 803
Genoa 768
Rapallo 182
Vado Ligure 136
Bordighera 14
Beijing 5
Arequipa 1
Hanoi 1
Ho Chi Minh City 1
Iguape 1
Reconquista 1
Rome 1
Singapore 1
Totale 1.915
Nome #
Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine 176
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification. 172
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 166
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? 157
Teriflunomide treatment reduces B cells in patients with MS. 141
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection. 138
JCV-DNA testing during natalizumab treatment is complementary to anti-JCV antibodies for PML risk stratification 118
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 107
Natural killer cells are functionally defective in multiple sclerosis 93
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 89
Human B cells express Neuron/Glial 2 antigen. Possible implications for health and autoimmune disease of the central nervous system. 88
The PRESTO study: awareness of stroke symptoms and time from onset to intervention 84
Impaired suppressor function of NK cells in multiple sclerosis 84
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 77
Impaired suppressor function of CD56bright NK cells in early multiple sclerosis 76
How can we define a brain health chart? A narrative review and a proposal 62
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: who gains from it? 61
Penetrance of the V203I variant of the PRNP gene: report of a patient with stroke-like onset of Creutzfeld-Jacob Disease and review of published cases 60
Cerebrospinal Fluid Biomarkers Profiling in Cerebral Amyloid Angiopathy and Relationship With Disease Phenotypes 15
Totale 1.964
Categoria #
all - tutte 7.440
article - articoli 7.116
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.556


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202181 0 0 0 8 2 8 5 7 5 12 9 25
2021/2022177 6 10 11 16 11 11 9 42 16 15 10 20
2022/2023226 20 28 8 16 34 38 0 13 33 5 26 5
2023/2024183 6 17 10 25 14 21 24 17 9 8 9 23
2024/2025395 17 28 7 32 35 36 40 88 12 14 40 46
2025/2026320 105 46 85 84 0 0 0 0 0 0 0 0
Totale 1.964